Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
GT Biopharma (GTBP)
NASDAQ:GTBP
GT Biopharma (GTBP) Stock Price & Analysis
171 Followers
GTBP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.18 - $2.30
Previous Close$0.25
Volume266.83K
Average Volume (3M)332.61K
Market Cap
$10.01M
Enterprise ValueN/A
Total Cash (Recent Filing)$17.97M
Total Debt (Recent Filing)$120.00K
Price to Earnings (P/E)-0.6
Beta1.01
Next Earnings
Nov 16, 2023EPS Estimate
-$0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding40,639,688
10 Day Avg. Volume162,151
30 Day Avg. Volume332,613
Standard Deviation0.34
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.85
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio2502.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$5.00Price Target Upside1900.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
GT Biopharma News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GTBP FAQ
What was GT Biopharma’s price range in the past 12 months?
GT Biopharma lowest stock price was $0.18 and its highest was $2.30 in the past 12 months.
What is GT Biopharma’s market cap?
Currently, no data Available
When is GT Biopharma’s upcoming earnings report date?
GT Biopharma’s upcoming earnings report date is Nov 16, 2023 which is in 51 days.
How were GT Biopharma’s earnings last quarter?
GT Biopharma released its earnings results on Aug 07, 2023. The company reported -$0.055 earnings per share for the quarter, beating the consensus estimate of -$0.1 by $0.045.
Is GT Biopharma overvalued?
According to Wall Street analysts GT Biopharma’s price is currently Undervalued.
Does GT Biopharma pay dividends?
GT Biopharma does not currently pay dividends.
What is GT Biopharma’s EPS estimate?
GT Biopharma’s EPS estimate is -$0.09.
How many shares outstanding does GT Biopharma have?
GT Biopharma has 40,639,687 shares outstanding.
What happened to GT Biopharma’s price movement after its last earnings report?
GT Biopharma reported an EPS of -$0.055 in its last earnings report, beating expectations of -$0.1. Following the earnings report the stock price went up 3.704%.
Which hedge fund is a major shareholder of GT Biopharma?
Currently, no hedge funds are holding shares in GTBP
---
GT Biopharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.88%
12-Months-Change
Fundamentals
Return on Equity
-107.96%
Trailing 12-Months
Asset Growth
-24.93%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
GT Biopharma
GT Biopharma, Inc. is engages in the development and commercialization of novel immuno-oncology products. Its products include OXS-1550, OXS-1650, OXS-3550, OXS-4550, OXS-1750, OXS-1950, and OXS-2050. The company was founded in 1965 and is headquartered in Westlake Village, CA.
---
Top 5 ETFs holding GTBP
Vanguard Total Stock Market ETF
$209.97K
Up to five ETFs with an Outperform Smart Score that hold GTBP. The ETFs are listed according to market value of GTBP within the ETF
---